ST3GAL1 and breast cancer: Two recent studies demonstrated that expression of the α2,3-sialic acid residues in breast cancer is associated with metastatic potential and overexpression of ST3Gal-I in transgenic mice promoted mammary tumorigenesis [24], [25].